首页> 美国卫生研究院文献>Journal of the National Medical Association >Plasma lipids lipoproteins and apolipoproteins in Nigerian diabetes mellitus essential hypertension and hypertensive-diabetic patients.
【2h】

Plasma lipids lipoproteins and apolipoproteins in Nigerian diabetes mellitus essential hypertension and hypertensive-diabetic patients.

机译:尼日利亚糖尿病原发性高血压和高血压糖尿病患者的血浆脂质脂蛋白和载脂蛋白。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Plasma lipids, lipoproteins, and apolipoproteins were assessed in three groups of Nigerians at increased risk for atherosclerotic heart disease. The three patient groups, diabetes mellitus (n = 15), essential hypertension (n = 12), and hypertensive-diabetes mellitus (n = 11), were compared with age-matched, apparently healthy controls (n = 14). In subjects with diabetes mellitus, triglyceride and its related apolipoproteins CIII and CIII:NonB were significantly higher than controls. High-density lipoprotein cholesterol (HDL-C) was significantly lower; its related ratios, total/HDL-C and low-density lipoprotein cholesterol (LDL-C)/HDL-C were significantly higher than those for controls. Subjects with hypertension and hypertensive-diabetes mellitus had significantly higher values than controls for those lipids and lipid fractions considered atherogenic (total cholesterol, LDL-C, triglyceride, and the total/HDL-C and LDL-C/HDL-C ratios) as well as apolipoproteins B, CIII, and lipoprotein particles Lp(a) and CIII:NonB. Only hypertensive-diabetes mellitus subjects had lower HDL-C levels, while hypertension patients had significantly higher apolipoprotein AI and LpAI concentrations than controls. Subjects with hypertensive-diabetes mellitus had significantly worse lipid, lipoprotein, and apolipoprotein profiles both in terms of increased atherogenic and reduced anti-atherogenic parameters compared with subjects with diabetes mellitus or hypertension only. These studies suggest that Nigerians with diabetes, hypertension, and especially both hypertension and diabetes need to be fully evaluated from a lipid and lipoprotein standpoint, and any abnormalities detected need to be taken into consideration during therapy of this group of high-risk patients.
机译:在三组患动脉粥样硬化性心脏病的风险增加的尼日利亚人中评估了血浆脂质,脂蛋白和载脂蛋白。将三个患者组(糖尿病(n = 15),原发性高血压(n = 12)和高血压糖尿病(n = 11))与年龄相匹配的,显然健康的对照组(n = 14)进行了比较。在患有糖尿病的受试者中,甘油三酸酯及其相关载脂蛋白CIII和CIII:NonB显着高于对照组。高密度脂蛋白胆固醇(HDL-C)明显降低;其相关比率,总/ HDL-C和低密度脂蛋白胆固醇(LDL-C)/ HDL-C显着高于对照组。高血压和高血压糖尿病患者的被测动脉粥样硬化的血脂和血脂分数(总胆固醇,LDL-C,甘油三酸酯以及总/ HDL-C和LDL-C / HDL-C比)的值明显高于对照组。以及载脂蛋白B,CIII和脂蛋白颗粒Lp(a)和CIII:NonB。只有高血压糖尿病患者的HDL-C水平较低,而高血压患者的载脂蛋白AI和LpAI浓度则明显高于对照组。与仅患有糖尿病或高血压的受试者相比,就增加的动脉粥样硬化和降低的抗动脉粥样硬化参数而言,患有高血压糖尿病的受试者的脂质,脂蛋白和载脂蛋白谱显着更差。这些研究表明,从脂质和脂蛋白的角度出发,需要对患有糖尿病,高血压,尤其是高血压和糖尿病的尼日利亚人进行全面评估,并且在治疗这一组高危患者时应考虑检测到的任何异常情况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号